InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: loanranger post# 159913

Thursday, 09/22/2016 1:01:19 AM

Thursday, September 22, 2016 1:01:19 AM

Post# of 403254
It's obvious the bigger issue is with "future funding" with the uncertainty being "stock price" and the market (OTC) they trade on. Good luck raising 30 million "over 2 years" with the current situation... Exactly why B is put on-hold regardless of FDA clearing the hurdles to start phase 3.


We are estimating that Phase 3 studies will cost approximately $30 million over about two years, which means we need to raise some additional capital to conduct that research and move forward with all the other drugs we're developing."
"I believe that it is best for us to focus on the other more cost-effective trials at present and wait for upcoming milestones that can assist in recovery of CTIX share value so as to minimize dilution when raising capital for the ABSSSI trial."
Dr. B. 7/13/16
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News